-
1
-
-
33846457870
-
Cancer statistics, 2007
-
10.3322/canjclin.57.1.43 17237035
-
A. Jemal R. Siegel E. Ward T. Murray J. Xu M.J. Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66 10.3322/canjclin.57.1.43 17237035
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
2
-
-
0034614637
-
The hallmarks of cancer
-
10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10647931
-
D. Hanahan R.A. Weinberg 2000 The hallmarks of cancer Cell 100 57 70 10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10647931
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
3
-
-
0029843950
-
Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
-
10.1073/pnas.93.18.9821 1:CAS:528:DyaK28XlsFeht7Y%3D 8790415
-
J.G. Herman J.R. Graff S. Myohanen B.D. Nelkin S.B. Baylin 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 9821 9826 10.1073/pnas.93.18.9821 1:CAS:528:DyaK28XlsFeht7Y%3D 8790415
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 9821-9826
-
-
Herman, J.G.1
Graff, J.R.2
Myohanen, S.3
Nelkin, B.D.4
Baylin, S.B.5
-
4
-
-
0035870248
-
A gene hypermethylation profile of human cancer
-
1:CAS:528:DC%2BD3MXjtFSjt7g%3D 11309270
-
M. Esteller P.G. Corn S.B. Baylin J.G. Herman 2001 A gene hypermethylation profile of human cancer Cancer Res 61 3225 3229 1:CAS:528:DC%2BD3MXjtFSjt7g%3D 11309270
-
(2001)
Cancer Res
, vol.61
, pp. 3225-3229
-
-
Esteller, M.1
Corn, P.G.2
Baylin, S.B.3
Herman, J.G.4
-
5
-
-
0036274359
-
The fundamental role of epigenetic events in cancer
-
10.1038/nrg962 1:CAS:528:DC%2BD38XksFOmsrw%3D 12042769
-
P.A. Jones S.B. Baylin 2002 The fundamental role of epigenetic events in cancer Nat Rev Genet 3 415 428 10.1038/nrg962 1:CAS:528:DC%2BD38XksFOmsrw%3D 12042769
-
(2002)
Nat Rev Genet
, vol.3
, pp. 415-428
-
-
Jones, P.A.1
Baylin, S.B.2
-
6
-
-
35948990450
-
Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer
-
10.1158/1078-0432.CCR-07-0591 1:CAS:528:DC%2BD2sXhtFygs7bJ 17947472
-
M. Suzuki H. Shigematsu T. Nakajima R. Kubo S. Motohashi Y. Sekine, et al. 2007 Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer Clin Cancer Res 13 6087 6092 10.1158/1078-0432.CCR-07-0591 1:CAS:528:DC%2BD2sXhtFygs7bJ 17947472
-
(2007)
Clin Cancer Res
, vol.13
, pp. 6087-6092
-
-
Suzuki, M.1
Shigematsu, H.2
Nakajima, T.3
Kubo, R.4
Motohashi, S.5
Sekine, Y.6
-
7
-
-
12144286953
-
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types
-
10.1002/ijc.20041 1:CAS:528:DC%2BD2cXivFCksr0%3D 14999791
-
N. Shivapurkar S. Toyooka K.O. Toyooka J. Reddy K. Miyajima M. Suzuki, et al. 2004 Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types Int J Cancer 109 786 792 10.1002/ijc.20041 1:CAS:528:DC%2BD2cXivFCksr0%3D 14999791
-
(2004)
Int J Cancer
, vol.109
, pp. 786-792
-
-
Shivapurkar, N.1
Toyooka, S.2
Toyooka, K.O.3
Reddy, J.4
Miyajima, K.5
Suzuki, M.6
-
8
-
-
12444282686
-
Epigenetic down-regulation of deathassociated protein kinase in lung cancers
-
1:CAS:528:DC%2BD3sXmtF2hs78%3D 12912953
-
S. Toyooka K.O. Toyooka K. Miyajima J.L. Reddy M. Toyota U.G. Sathyanarayana, et al. 2003 Epigenetic down-regulation of deathassociated protein kinase in lung cancers Clin Cancer Res 9 3034 3041 1:CAS:528: DC%2BD3sXmtF2hs78%3D 12912953
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3034-3041
-
-
Toyooka, S.1
Toyooka, K.O.2
Miyajima, K.3
Reddy, J.L.4
Toyota, M.5
Sathyanarayana, U.G.6
-
9
-
-
33646345615
-
Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer
-
10.1002/cncr.21853 1:CAS:528:DC%2BD28XkvFOnt7k%3D 16598760
-
M. Suzuki H. Shigematsu T. Iizasa K. Hiroshima Y. Nakatani J.D. Minna, et al. 2006 Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer Cancer 106 2200 2207 10.1002/cncr.21853 1:CAS:528:DC%2BD28XkvFOnt7k%3D 16598760
-
(2006)
Cancer
, vol.106
, pp. 2200-2207
-
-
Suzuki, M.1
Shigematsu, H.2
Iizasa, T.3
Hiroshima, K.4
Nakatani, Y.5
Minna, J.D.6
-
10
-
-
24744466279
-
Aberrant methylation of FBN2 in human non-small cell lung cancer
-
10.1016/j.lungcan.2005.04.013 15951052
-
H. Chen M. Suzuki Y. Nakamura M. Ohira S. Ando T. Iida, et al. 2005 Aberrant methylation of FBN2 in human non-small cell lung cancer Lung Cancer 50 43 49 10.1016/j.lungcan.2005.04.013 15951052
-
(2005)
Lung Cancer
, vol.50
, pp. 43-49
-
-
Chen, H.1
Suzuki, M.2
Nakamura, Y.3
Ohira, M.4
Ando, S.5
Iida, T.6
-
11
-
-
2342575723
-
RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene reexpression in human lung and breast cancer cells
-
10.1158/0008-5472.CAN-03-3046 1:CAS:528:DC%2BD2cXjs1ehtrc%3D 15126351
-
M. Suzuki N. Sunaga D.S. Shames S. Toyooka A.F. Gazdar J.D. Minna 2004 RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene reexpression in human lung and breast cancer cells Cancer Res 64 3137 3143 10.1158/0008-5472.CAN-03-3046 1:CAS:528: DC%2BD2cXjs1ehtrc%3D 15126351
-
(2004)
Cancer Res
, vol.64
, pp. 3137-3143
-
-
Suzuki, M.1
Sunaga, N.2
Shames, D.S.3
Toyooka, S.4
Gazdar, A.F.5
Minna, J.D.6
-
13
-
-
85047698762
-
Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers
-
10.1038/sj.onc.1205303 1:CAS:528:DC%2BD38XivFyku7o%3D 11948426
-
H. Osada Y. Tatematsu Y. Yatabe T. Nakagawa H. Konishi T. Harano, et al. 2002 Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers Oncogene 21 2418 2424 10.1038/sj.onc.1205303 1:CAS:528:DC%2BD38XivFyku7o%3D 11948426
-
(2002)
Oncogene
, vol.21
, pp. 2418-2424
-
-
Osada, H.1
Tatematsu, Y.2
Yatabe, Y.3
Nakagawa, T.4
Konishi, H.5
Harano, T.6
-
14
-
-
2542576634
-
Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis
-
10.1093/carcin/bgh038 1:CAS:528:DC%2BD2cXisF2lt7w%3D 14656941
-
B.R. Vuillemenot L.C. Pulling W.A. Palmisano J.A. Hutt S.A. Belinsky 2004 Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis Carcinogenesis 25 623 629 10.1093/carcin/bgh038 1:CAS:528:DC%2BD2cXisF2lt7w%3D 14656941
-
(2004)
Carcinogenesis
, vol.25
, pp. 623-629
-
-
Vuillemenot, B.R.1
Pulling, L.C.2
Palmisano, W.A.3
Hutt, J.A.4
Belinsky, S.A.5
-
15
-
-
18344390653
-
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
-
10.1038/416552a 1:CAS:528:DC%2BD38XivVOnurw%3D 11932749
-
I. Rhee K.E. Bachman B.H. Park K.W. Jair R.W. Yen K.E. Schuebel, et al. 2002 DNMT1 and DNMT3b cooperate to silence genes in human cancer cells Nature 416 552 556 10.1038/416552a 1:CAS:528:DC%2BD38XivVOnurw%3D 11932749
-
(2002)
Nature
, vol.416
, pp. 552-556
-
-
Rhee, I.1
Bachman, K.E.2
Park, B.H.3
Jair, K.W.4
Yen, R.W.5
Schuebel, K.E.6
-
16
-
-
0037224722
-
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
-
10.1038/ng1068 1:CAS:528:DC%2BD38XpvVeqsL4%3D 12496760
-
M.F. Robert S. Morin N. Beaulieu F. Gauthier I.C. Chute A. Barsalou, et al. 2003 DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells Nat Genet 33 61 65 10.1038/ng1068 1:CAS:528:DC%2BD38XpvVeqsL4%3D 12496760
-
(2003)
Nat Genet
, vol.33
, pp. 61-65
-
-
Robert, M.F.1
Morin, S.2
Beaulieu, N.3
Gauthier, F.4
Chute, I.C.5
Barsalou, A.6
-
17
-
-
3042638418
-
Molecular diagnostic applications of DNA methylation technology
-
10.1016/j.clinbiochem.2004.05.010 1:CAS:528:DC%2BD2cXltl2gtbg%3D 15234241
-
S.E. Cottrell 2004 Molecular diagnostic applications of DNA methylation technology Clin Biochem 37 595 604 10.1016/j.clinbiochem.2004.05.010 1:CAS:528:DC%2BD2cXltl2gtbg%3D 15234241
-
(2004)
Clin Biochem
, vol.37
, pp. 595-604
-
-
Cottrell, S.E.1
-
18
-
-
0037355974
-
Sensitive detection of DNA methylation
-
10.1111/j.1749-6632.2003.tb05967.x 1:CAS:528:DC%2BD3sXjt1yrs7c%3D 12724217
-
S.E. Cottrell P.W. Laird 2003 Sensitive detection of DNA methylation Ann N Y Acad Sci 983 120 130 10.1111/j.1749-6632.2003.tb05967.x 1:CAS:528: DC%2BD3sXjt1yrs7c%3D 12724217
-
(2003)
Ann N y Acad Sci
, vol.983
, pp. 120-130
-
-
Cottrell, S.E.1
Laird, P.W.2
-
19
-
-
48249117114
-
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
-
10.1038/sj.bjc.6604452 1:CAS:528:DC%2BD1cXosFWntrg%3D 18594535
-
T.J. Seng N. Currey W.A. Cooper C.S. Lee C. Chan L. Horvath, et al. 2008 DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma Br J Cancer 99 375 382 10.1038/sj.bjc.6604452 1:CAS:528:DC%2BD1cXosFWntrg%3D 18594535
-
(2008)
Br J Cancer
, vol.99
, pp. 375-382
-
-
Seng, T.J.1
Currey, N.2
Cooper, W.A.3
Lee, C.S.4
Chan, C.5
Horvath, L.6
-
20
-
-
51049091703
-
Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis
-
1:CAS:528:DC%2BD1cXptVWnu7o%3D 18575756
-
M. Suzuki S. Mohamed T. Nakajima R. Kubo L. Tian T. Fujiwara, et al. 2008 Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis Int J Oncol 33 113 119 1:CAS:528:DC%2BD1cXptVWnu7o%3D 18575756
-
(2008)
Int J Oncol
, vol.33
, pp. 113-119
-
-
Suzuki, M.1
Mohamed, S.2
Nakajima, T.3
Kubo, R.4
Tian, L.5
Fujiwara, T.6
-
21
-
-
37049001894
-
Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features
-
10.1002/cncr.23113 1:CAS:528:DC%2BD1cXitVOnsQ%3D%3D 17960794
-
D.S. Kim M.J. Kim J.Y. Lee Y.Z. Kim E.J. Kim J.Y. Park 2007 Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features Cancer 110 2785 2792 10.1002/cncr.23113 1:CAS:528:DC%2BD1cXitVOnsQ%3D%3D 17960794
-
(2007)
Cancer
, vol.110
, pp. 2785-2792
-
-
Kim, D.S.1
Kim, M.J.2
Lee, J.Y.3
Kim, Y.Z.4
Kim, E.J.5
Park, J.Y.6
-
22
-
-
34548513807
-
Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers
-
10.1016/j.lungcan.2007.05.011 17606310
-
N. Yanagawa G. Tamura H. Oizumi N. Kanauchi M. Endoh M. Sadahiro, et al. 2007 Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers Lung Cancer 58 131 138 10.1016/j.lungcan.2007.05.011 17606310
-
(2007)
Lung Cancer
, vol.58
, pp. 131-138
-
-
Yanagawa, N.1
Tamura, G.2
Oizumi, H.3
Kanauchi, N.4
Endoh, M.5
Sadahiro, M.6
-
23
-
-
33846187641
-
Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer
-
10.1158/1078-0432.CCR-06-0894 1:CAS:528:DC%2BD28XhtlCrtr%2FM 17189404
-
J. Gu D. Berman C. Lu I.I. Wistuba J.A. Roth M. Frazier, et al. 2006 Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer Clin Cancer Res 12 7329 7338 10.1158/1078-0432.CCR-06-0894 1:CAS:528:DC%2BD28XhtlCrtr%2FM 17189404
-
(2006)
Clin Cancer Res
, vol.12
, pp. 7329-7338
-
-
Gu, J.1
Berman, D.2
Lu, C.3
Wistuba, I.I.4
Roth, J.A.5
Frazier, M.6
-
24
-
-
33750724417
-
Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis
-
1:CAS:528:DC%2BD28Xht1Gmt7zL 17094392
-
N. Ota K. Kawakami T. Okuda A. Takehara C. Hiranuma K. Oyama, et al. 2006 Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis Anticancer Res 26 3729 3732 1:CAS:528:DC%2BD28Xht1Gmt7zL 17094392
-
(2006)
Anticancer Res
, vol.26
, pp. 3729-3732
-
-
Ota, N.1
Kawakami, K.2
Okuda, T.3
Takehara, A.4
Hiranuma, C.5
Oyama, K.6
-
25
-
-
33748357288
-
Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer
-
10.3816/CLC.2006.n.035 1:CAS:528:DC%2BD28XovFGitrw%3D 16870048
-
Z. Zhang S. Tan L. Zhang 2006 Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer Clin Lung Cancer 8 62 65 10.3816/CLC.2006.n.035 1:CAS:528:DC%2BD28XovFGitrw%3D 16870048
-
(2006)
Clin Lung Cancer
, vol.8
, pp. 62-65
-
-
Zhang, Z.1
Tan, S.2
Zhang, L.3
-
26
-
-
33646230046
-
Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage i non-small cell lung cancer
-
10.1158/0008-5472.CAN-05-3813 1:CAS:528:DC%2BD28XjsFSltr4%3D 16618724
-
J.S. Kim J.W. Kim J. Han Y.M. Shim J. Park D.H. Kim 2006 Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer Cancer Res 66 4049 4054 10.1158/0008-5472.CAN-05-3813 1:CAS:528:DC%2BD28XjsFSltr4%3D 16618724
-
(2006)
Cancer Res
, vol.66
, pp. 4049-4054
-
-
Kim, J.S.1
Kim, J.W.2
Han, J.3
Shim, Y.M.4
Park, J.5
Kim, D.H.6
-
27
-
-
23044491195
-
Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer
-
10.1158/1078-0432.CCR-05-0601 1:CAS:528:DC%2BD2MXmvFSmtb4%3D 16061855
-
H.S. Hsu C.K. Wen Y.A. Tang R.K. Lin W.Y. Li W.H. Hsu, et al. 2005 Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer Clin Cancer Res 11 5410 5416 10.1158/1078-0432.CCR-05-0601 1:CAS:528: DC%2BD2MXmvFSmtb4%3D 16061855
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5410-5416
-
-
Hsu, H.S.1
Wen, C.K.2
Tang, Y.A.3
Lin, R.K.4
Li, W.Y.5
Hsu, W.H.6
-
28
-
-
28044451106
-
Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer
-
10.1002/ijc.21278 1:CAS:528:DC%2BD2MXht1CntLfP 15986439
-
J.C. Lai Y.W. Cheng H.L. Chiou M.F. Wu C.Y. Chen H. Lee 2005 Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer Int J Cancer 117 974 980 10.1002/ijc.21278 1:CAS:528:DC%2BD2MXht1CntLfP 15986439
-
(2005)
Int J Cancer
, vol.117
, pp. 974-980
-
-
Lai, J.C.1
Cheng, Y.W.2
Chiou, H.L.3
Wu, M.F.4
Chen, C.Y.5
Lee, H.6
-
29
-
-
16544395214
-
Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer
-
10.1158/1078-0432.CCR-04-0652 1:CAS:528:DC%2BD2cXnvVOjs74%3D 15447998
-
J. Wang J.J. Lee L. Wang D.D. Liu C. Lu Y.H. Fan, et al. 2004 Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer Clin Cancer Res 10 6119 6125 10.1158/1078-0432.CCR-04-0652 1:CAS:528:DC%2BD2cXnvVOjs74%3D 15447998
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6119-6125
-
-
Wang, J.1
Lee, J.J.2
Wang, L.3
Liu, D.D.4
Lu, C.5
Fan, Y.H.6
-
30
-
-
1642400575
-
Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma
-
10.1002/cncr.20144 1:CAS:528:DC%2BD2cXjt1Sru7o%3D 15042681
-
R. Maruyama K. Sugio I. Yoshino Y. Maehara A.F. Gazdar 2004 Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma Cancer 100 1472 1477 10.1002/cncr.20144 1:CAS:528:DC%2BD2cXjt1Sru7o%3D 15042681
-
(2004)
Cancer
, vol.100
, pp. 1472-1477
-
-
Maruyama, R.1
Sugio, K.2
Yoshino, I.3
Maehara, Y.4
Gazdar, A.F.5
-
31
-
-
12244297095
-
Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: Associations with clinical outcome
-
1:CAS:528:DC%2BD3sXnt1OksQ%3D%3D 12538473
-
J. Brabender H. Usadel R. Metzger P.M. Schneider J. Park D. Salonga, et al. 2003 Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome Clin Cancer Res 9 223 227 1:CAS:528:DC%2BD3sXnt1OksQ%3D%3D 12538473
-
(2003)
Clin Cancer Res
, vol.9
, pp. 223-227
-
-
Brabender, J.1
Usadel, H.2
Metzger, R.3
Schneider, P.M.4
Park, J.5
Salonga, D.6
-
32
-
-
0036894939
-
Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage i nonsmall cell lung cancer
-
1:CAS:528:DC%2BD38XpslCjtrw%3D 12473575
-
Y.S. Chang L. Wang D. Liu L. Mao W.K. Hong F.R. Khuri, et al. 2002 Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I nonsmall cell lung cancer Clin Cancer Res 8 3669 3675 1:CAS:528:DC%2BD38XpslCjtrw%3D 12473575
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3669-3675
-
-
Chang, Y.S.1
Wang, L.2
Liu, D.3
Mao, L.4
Hong, W.K.5
Khuri, F.R.6
-
33
-
-
0037081085
-
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer
-
1:CAS:528:DC%2BD38XhtVyhsbk%3D 11809682
-
H. Usadel J. Brabender K.D. Danenberg C. Jeronimo S. Harden J. Engles, et al. 2002 Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 371 375 1:CAS:528:DC%2BD38XhtVyhsbk%3D 11809682
-
(2002)
Cancer Res
, vol.62
, pp. 371-375
-
-
Usadel, H.1
Brabender, J.2
Danenberg, K.D.3
Jeronimo, C.4
Harden, S.5
Engles, J.6
-
34
-
-
0035858994
-
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival
-
10.1038/sj.onc.1204455 1:CAS:528:DC%2BD3MXkvValsL4%3D 11429699
-
J. Brabender H. Usadel K.D. Danenberg R. Metzger P.M. Schneider R.V. Lord, et al. 2001 Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival Oncogene 20 3528 3532 10.1038/sj.onc.1204455 1:CAS:528:DC%2BD3MXkvValsL4%3D 11429699
-
(2001)
Oncogene
, vol.20
, pp. 3528-3532
-
-
Brabender, J.1
Usadel, H.2
Danenberg, K.D.3
Metzger, R.4
Schneider, P.M.5
Lord, R.V.6
-
35
-
-
0035870282
-
P16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer
-
1:CAS:528:DC%2BD3MXjtFSjurY%3D 11309302
-
D.H. Kim H.H. Nelson J.K. Wiencke S. Zheng D.C. Christiani J.C. Wain, et al. 2001 p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer Cancer Res 61 3419 3424 1:CAS:528:DC%2BD3MXjtFSjurY%3D 11309302
-
(2001)
Cancer Res
, vol.61
, pp. 3419-3424
-
-
Kim, D.H.1
Nelson, H.H.2
Wiencke, J.K.3
Zheng, S.4
Christiani, D.C.5
Wain, J.C.6
-
36
-
-
0034692447
-
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage i non-small-cell lung cancer
-
10.1093/jnci/92.18.1511 1:CAS:528:DC%2BD3cXntFKqsr0%3D 10995806
-
X. Tang F.R. Khuri J.J. Lee B.L. Kemp D. Liu W.K. Hong, et al. 2000 Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer J Natl Cancer Inst 92 1511 1516 10.1093/jnci/92.18.1511 1:CAS:528:DC%2BD3cXntFKqsr0%3D 10995806
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1511-1516
-
-
Tang, X.1
Khuri, F.R.2
Lee, J.J.3
Kemp, B.L.4
Liu, D.5
Hong, W.K.6
-
37
-
-
40849124009
-
DNA methylation markers and early recurrence in stage i lung cancer
-
10.1056/NEJMoa0706550 1:CAS:528:DC%2BD1cXjt1aiurc%3D 18337602
-
M.V. Brock C.M. Hooker E. Ota-Machida Y. Han M. Guo S. Ames, et al. 2008 DNA methylation markers and early recurrence in stage I lung cancer N Engl J Med 358 1118 1128 10.1056/NEJMoa0706550 1:CAS:528:DC%2BD1cXjt1aiurc%3D 18337602
-
(2008)
N Engl J Med
, vol.358
, pp. 1118-1128
-
-
Brock, M.V.1
Hooker, C.M.2
Ota-Machida, E.3
Han, Y.4
Guo, M.5
Ames, S.6
-
38
-
-
33847704518
-
Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine
-
10.1016/j.lungcan.2006.11.016 17196704
-
J.R. Fischer U. Ohnmacht N. Rieger M. Zemaitis C. Stoffregen C. Manegold, et al. 2007 Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine Lung Cancer 56 115 123 10.1016/j.lungcan.2006.11.016 17196704
-
(2007)
Lung Cancer
, vol.56
, pp. 115-123
-
-
Fischer, J.R.1
Ohnmacht, U.2
Rieger, N.3
Zemaitis, M.4
Stoffregen, C.5
Manegold, C.6
-
39
-
-
33644824212
-
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group
-
10.1200/JCO.2005.02.2905 1:CAS:528:DC%2BD28Xnt1ygtA%3D%3D 16361617
-
J.L. Ramirez R. Rosell M. Taron M. Sanchez-Ronco V. Alberola R. de Las Penas, et al. 2005 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group J Clin Oncol 23 9105 9112 10.1200/JCO.2005.02.2905 1:CAS:528:DC%2BD28Xnt1ygtA%3D%3D 16361617
-
(2005)
J Clin Oncol
, vol.23
, pp. 9105-9112
-
-
Ramirez, J.L.1
Rosell, R.2
Taron, M.3
Sanchez-Ronco, M.4
Alberola, V.5
De Las Penas, R.6
-
40
-
-
0037089460
-
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers
-
1:CAS:528:DC%2BD38Xjt1ejurk%3D 11956099
-
S.A. Belinsky W.A. Palmisano F.D. Gilliland L.A. Crooks K.K. Divine S.A. Winters, et al. 2002 Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers Cancer Res 62 2370 2377 1:CAS:528:DC%2BD38Xjt1ejurk%3D 11956099
-
(2002)
Cancer Res
, vol.62
, pp. 2370-2377
-
-
Belinsky, S.A.1
Palmisano, W.A.2
Gilliland, F.D.3
Crooks, L.A.4
Divine, K.K.5
Winters, S.A.6
-
41
-
-
0034326238
-
Predicting lung cancer by detecting aberrant promoter methylation in sputum
-
1:CAS:528:DC%2BD3cXotV2lsrk%3D 11085511
-
W.A. Palmisano K.K. Divine G. Saccomanno F.D. Gilliland S.B. Baylin J.G. Herman, et al. 2000 Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Res 60 5954 5958 1:CAS:528:DC%2BD3cXotV2lsrk%3D 11085511
-
(2000)
Cancer Res
, vol.60
, pp. 5954-5958
-
-
Palmisano, W.A.1
Divine, K.K.2
Saccomanno, G.3
Gilliland, F.D.4
Baylin, S.B.5
Herman, J.G.6
-
42
-
-
41549102574
-
Molecular alterations in spontaneous sputum of cancer-free heavy smokers: Results from a large screening program
-
10.1158/1078-0432.CCR-07-1741 1:CAS:528:DC%2BD1cXjtleisL8%3D 18347195
-
E. Baryshnikova A. Destro M.V. Infante S. Cavuto U. Cariboni M. Alloisio, et al. 2008 Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program Clin Cancer Res 14 1913 1919 10.1158/1078-0432.CCR-07-1741 1:CAS:528:DC%2BD1cXjtleisL8%3D 18347195
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1913-1919
-
-
Baryshnikova, E.1
Destro, A.2
Infante, M.V.3
Cavuto, S.4
Cariboni, U.5
Alloisio, M.6
-
43
-
-
36749089037
-
Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment
-
10.1002/path.2246 1:CAS:528:DC%2BD1cXhvFKisg%3D%3D 17973238
-
H.S. Hsu T.P. Chen C.K. Wen C.H. Hung C.Y. Chen J.T. Chen, et al. 2007 Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment J Pathol 213 412 419 10.1002/path.2246 1:CAS:528: DC%2BD1cXhvFKisg%3D%3D 17973238
-
(2007)
J Pathol
, vol.213
, pp. 412-419
-
-
Hsu, H.S.1
Chen, T.P.2
Wen, C.K.3
Hung, C.H.4
Chen, C.Y.5
Chen, J.T.6
-
44
-
-
42149114024
-
Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: A promising cancer biomarker assay
-
10.1158/1055-9965.EPI-07-2808 1:CAS:528:DC%2BD1cXkslGqu7s%3D 18398044
-
N. Shivapurkar V. Stastny Y. Xie C. Prinsen E. Frenkel B. Czerniak, et al. 2008 Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay Cancer Epidemiol Biomarkers Prev 17 995 1000 10.1158/1055-9965.EPI-07-2808 1:CAS:528:DC%2BD1cXkslGqu7s%3D 18398044
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 995-1000
-
-
Shivapurkar, N.1
Stastny, V.2
Xie, Y.3
Prinsen, C.4
Frenkel, E.5
Czerniak, B.6
-
45
-
-
38449110073
-
Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3
-
1:CAS:528:DC%2BD2sXhtlKhsr%2FI 17914577
-
S.H. Tan H. Ida Q.C. Lau B.C. Goh W.S. Chieng M. Loh, et al. 2007 Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3 Oncol Rep 18 1225 1230 1:CAS:528:DC%2BD2sXhtlKhsr%2FI 17914577
-
(2007)
Oncol Rep
, vol.18
, pp. 1225-1230
-
-
Tan, S.H.1
Ida, H.2
Lau, Q.C.3
Goh, B.C.4
Chieng, W.S.5
Loh, M.6
-
46
-
-
31944448123
-
P16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients
-
10.1002/jcp.20503 1:CAS:528:DC%2BD28XhsFWhtLk%3D 16222700
-
P. Ulivi W. Zoli D. Calistri F. Fabbri A. Tesei M. Rosetti, et al. 2006 p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients J Cell Physiol 206 611 615 10.1002/jcp.20503 1:CAS:528:DC%2BD28XhsFWhtLk%3D 16222700
-
(2006)
J Cell Physiol
, vol.206
, pp. 611-615
-
-
Ulivi, P.1
Zoli, W.2
Calistri, D.3
Fabbri, F.4
Tesei, A.5
Rosetti, M.6
-
47
-
-
19944433956
-
Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer
-
10.1158/1078-0432.CCR-04-2363 1:CAS:528:DC%2BD2MXht1yntLg%3D 15709192
-
K. Fujiwara N. Fujimoto M. Tabata K. Nishii K. Matsuo K. Hotta, et al. 2005 Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer Clin Cancer Res 11 1219 1225 10.1158/1078-0432.CCR-04-2363 1:CAS:528:DC%2BD2MXht1yntLg%3D 15709192
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1219-1225
-
-
Fujiwara, K.1
Fujimoto, N.2
Tabata, M.3
Nishii, K.4
Matsuo, K.5
Hotta, K.6
-
48
-
-
34347375106
-
Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications
-
10.1002/jcp.21066 1:CAS:528:DC%2BD2sXntlyqtro%3D 17458893
-
L. Sigalotti E. Fratta S. Coral E. Cortini A. Covre H.J. Nicolay, et al. 2007 Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications J Cell Physiol 212 330 344 10.1002/jcp.21066 1:CAS:528:DC%2BD2sXntlyqtro%3D 17458893
-
(2007)
J Cell Physiol
, vol.212
, pp. 330-344
-
-
Sigalotti, L.1
Fratta, E.2
Coral, S.3
Cortini, E.4
Covre, A.5
Nicolay, H.J.6
-
49
-
-
1642289104
-
5-aza-2′-deoxycytidine restores the E-cadherin system in E-cadherinsilenced cancer cells and reduces cancer metastasis
-
10.1023/B:CLIN.0000017180.19881.c1 1:CAS:528:DC%2BD2cXhsV2qu70%3D 15065602
-
J.S. Nam Y. Ino Y. Kanai M. Sakamoto S. Hirohashi 2004 5-aza-2′-deoxycytidine restores the E-cadherin system in E-cadherinsilenced cancer cells and reduces cancer metastasis Clin Exp Metastasis 21 49 56 10.1023/B:CLIN.0000017180.19881.c1 1:CAS:528: DC%2BD2cXhsV2qu70%3D 15065602
-
(2004)
Clin Exp Metastasis
, vol.21
, pp. 49-56
-
-
Nam, J.S.1
Ino, Y.2
Kanai, Y.3
Sakamoto, M.4
Hirohashi, S.5
-
50
-
-
31044451642
-
Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells
-
10.1016/j.jtcvs.2005.05.022 1:CAS:528:DC%2BD28XitFOrtLg%3D 16434257
-
E.S. Kassis M. Zhao J.A. Hong G.A. Chen D.M. Nguyen D.S. Schrump 2006 Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells J Thorac Cardiovasc Surg 131 298 306 10.1016/j.jtcvs.2005.05. 022 1:CAS:528:DC%2BD28XitFOrtLg%3D 16434257
-
(2006)
J Thorac Cardiovasc Surg
, vol.131
, pp. 298-306
-
-
Kassis, E.S.1
Zhao, M.2
Hong, J.A.3
Chen, G.A.4
Nguyen, D.M.5
Schrump, D.S.6
-
51
-
-
34748837820
-
Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells
-
10.1097/CAD.0b013e3282a215e9 1:CAS:528:DC%2BD2sXhtVOgurvM 17893516
-
R.K. Lin C.H. Hsu Y.C. Wang 2007 Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells Anticancer Drugs 18 1157 1164 10.1097/CAD.0b013e3282a215e9 1:CAS:528:DC%2BD2sXhtVOgurvM 17893516
-
(2007)
Anticancer Drugs
, vol.18
, pp. 1157-1164
-
-
Lin, R.K.1
Hsu, C.H.2
Wang, Y.C.3
-
52
-
-
0035196111
-
Potential of 5-aza-2′-deoxycytidine (Decitabine), a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer
-
10.1016/S0169-5002(01)00397-X 11742714
-
R.L. Momparler J. Ayoub 2001 Potential of 5-aza-2′-deoxycytidine (Decitabine), a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer Lung Cancer 34 suppl4 S111 S115 10.1016/S0169- 5002(01)00397-X 11742714
-
(2001)
Lung Cancer
, vol.34
, Issue.SUPPL. 4
-
-
Momparler, R.L.1
Ayoub, J.2
-
53
-
-
33750326078
-
Phase i study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura
-
10.1158/1078-0432.CCR-06-0669 1:CAS:528:DC%2BD28XhtVartbvF 17020984
-
D.S. Schrump M.R. Fischette D.M. Nguyen M. Zhao X. Li T.F. Kunst, et al. 2006 Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura Clin Cancer Res 12 5777 5785 10.1158/1078-0432.CCR-06-0669 1:CAS:528:DC%2BD28XhtVartbvF 17020984
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5777-5785
-
-
Schrump, D.S.1
Fischette, M.R.2
Nguyen, D.M.3
Zhao, M.4
Li, X.5
Kunst, T.F.6
-
54
-
-
34548395116
-
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
-
10.1093/annonc/mdm204 1:STN:280:DC%2BD2srhtFaqug%3D%3D 17761710
-
M. Candelaria D. Gallardo-Rincon C. Arce L. Cetina J.L. Aguilar-Ponce O. Arrieta, et al. 2007 A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors Ann Oncol 18 1529 1538 10.1093/annonc/mdm204 1:STN:280: DC%2BD2srhtFaqug%3D%3D 17761710
-
(2007)
Ann Oncol
, vol.18
, pp. 1529-1538
-
-
Candelaria, M.1
Gallardo-Rincon, D.2
Arce, C.3
Cetina, L.4
Aguilar-Ponce, J.L.5
Arrieta, O.6
-
55
-
-
33749483782
-
Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo
-
10.1158/0008-5472.CAN-06-1954 1:CAS:528:DC%2BD28Xps1aiu7g%3D 16982764
-
N. Shukeir P. Pakneshan G. Chen M. Szyf S.A. Rabbani 2006 Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo Cancer Res 66 9202 9210 10.1158/0008-5472.CAN-06-1954 1:CAS:528:DC%2BD28Xps1aiu7g%3D 16982764
-
(2006)
Cancer Res
, vol.66
, pp. 9202-9210
-
-
Shukeir, N.1
Pakneshan, P.2
Chen, G.3
Szyf, M.4
Rabbani, S.A.5
-
56
-
-
33645294070
-
Oncomirs - MicroRNAs with a role in cancer
-
10.1038/nrc1840 1:CAS:528:DC%2BD28XivVyqtrs%3D 16557279
-
A. Esquela-Kerscher F.J. Slack 2006 Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 259 269 10.1038/nrc1840 1:CAS:528:DC%2BD28XivVyqtrs%3D 16557279
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 259-269
-
-
Esquela-Kerscher, A.1
Slack, F.J.2
-
57
-
-
18344369543
-
MicroRNA biogenesis: Coordinated cropping and dicing
-
10.1038/nrm1644 1:CAS:528:DC%2BD2MXjvF2jsLg%3D 15852042
-
V.N. Kim 2005 MicroRNA biogenesis: coordinated cropping and dicing Nat Rev Mol Cell Biol 6 376 385 10.1038/nrm1644 1:CAS:528:DC%2BD2MXjvF2jsLg%3D 15852042
-
(2005)
Nat Rev Mol Cell Biol
, vol.6
, pp. 376-385
-
-
Kim, V.N.1
-
58
-
-
36749005527
-
Using expression profiling data to identify human microRNA targets
-
10.1038/nmeth1130 1:CAS:528:DC%2BD2sXhtlKlt7fE 18026111
-
J.C. Huang T. Babak T.W. Corson G. Chua S. Khan B.L. Gallie, et al. 2007 Using expression profiling data to identify human microRNA targets Nat Methods 4 1045 1049 10.1038/nmeth1130 1:CAS:528:DC%2BD2sXhtlKlt7fE 18026111
-
(2007)
Nat Methods
, vol.4
, pp. 1045-1049
-
-
Huang, J.C.1
Babak, T.2
Corson, T.W.3
Chua, G.4
Khan, S.5
Gallie, B.L.6
-
59
-
-
33847748913
-
The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function
-
10.1158/0008-5472.CAN-06-4074 1:CAS:528:DC%2BD2sXhvVWruro%3D 17308078
-
B. Brueckner C. Stresemann R. Kuner C. Mund T. Musch M. Meister, et al. 2007 The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function Cancer Res 67 1419 1423 10.1158/0008-5472.CAN-06-4074 1:CAS:528:DC%2BD2sXhvVWruro%3D 17308078
-
(2007)
Cancer Res
, vol.67
, pp. 1419-1423
-
-
Brueckner, B.1
Stresemann, C.2
Kuner, R.3
Mund, C.4
Musch, T.5
Meister, M.6
-
60
-
-
33847763576
-
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
-
10.1158/0008-5472.CAN-06-4218 1:CAS:528:DC%2BD2sXhvVWrurk%3D 17308079
-
A. Lujambio S. Ropero E. Ballestar M.F. Fraga C. Cerrato F. Setien, et al. 2007 Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res 67 1424 1429 10.1158/0008-5472.CAN-06-4218 1:CAS:528:DC%2BD2sXhvVWrurk%3D 17308079
-
(2007)
Cancer Res
, vol.67
, pp. 1424-1429
-
-
Lujambio, A.1
Ropero, S.2
Ballestar, E.3
Fraga, M.F.4
Cerrato, C.5
Setien, F.6
-
61
-
-
35649020283
-
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
-
10.1073/pnas.0707628104 1:CAS:528:DC%2BD2sXhtFGns7zL 17890317
-
M. Fabbri R. Garzon A. Cimmino Z. Liu N. Zanesi E. Callegari, et al. 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci U S A 104 15805 15810 10.1073/pnas.0707628104 1:CAS:528:DC%2BD2sXhtFGns7zL 17890317
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 15805-15810
-
-
Fabbri, M.1
Garzon, R.2
Cimmino, A.3
Liu, Z.4
Zanesi, N.5
Callegari, E.6
-
62
-
-
34250364447
-
Towards clinical application of methylated DNA sequences as cancer biomarkers: A joint NCI's EDRN and NIST Workshop on standards, methods, assays, reagents and tools
-
10.1158/0008-5472.CAN-06-2888 1:CAS:528:DC%2BD2sXltl2hurg%3D 17510378
-
J. Kagan S. Srivastava P.E. Barker S.A. Belinsky P. Cairns 2007 Towards clinical application of methylated DNA sequences as cancer biomarkers: A joint NCI's EDRN and NIST Workshop on standards, methods, assays, reagents and tools Cancer Res 67 4545 4549 10.1158/0008-5472.CAN-06-2888 1:CAS:528: DC%2BD2sXltl2hurg%3D 17510378
-
(2007)
Cancer Res
, vol.67
, pp. 4545-4549
-
-
Kagan, J.1
Srivastava, S.2
Barker, P.E.3
Belinsky, S.A.4
Cairns, P.5
-
63
-
-
13744264091
-
Epigenetic changes in prostate cancer: Implication for diagnosis and treatment
-
10.1093/jnci/dji010 1:CAS:528:DC%2BD2MXmsV2jtA%3D%3D 15657340
-
L.C. Li P.R. Carroll R. Dahiya 2005 Epigenetic changes in prostate cancer: implication for diagnosis and treatment J Natl Cancer Inst 97 103 115 10.1093/jnci/dji010 1:CAS:528:DC%2BD2MXmsV2jtA%3D%3D 15657340
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 103-115
-
-
Li, L.C.1
Carroll, P.R.2
Dahiya, R.3
-
64
-
-
2542577737
-
Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes
-
10.1158/0008-5472.CAN-03-3307 1:CAS:528:DC%2BD2cXksVKgurg%3D 15172980
-
N. Shivapurkar T. Takahashi J. Reddy Y. Zheng V. Stastny R. Collins, et al. 2004 Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes Cancer Res 64 3757 3760 10.1158/0008-5472.CAN-03- 3307 1:CAS:528:DC%2BD2cXksVKgurg%3D 15172980
-
(2004)
Cancer Res
, vol.64
, pp. 3757-3760
-
-
Shivapurkar, N.1
Takahashi, T.2
Reddy, J.3
Zheng, Y.4
Stastny, V.5
Collins, R.6
-
65
-
-
2942584857
-
SOCS1 and SHP1 hypermethylation in multiple myeloma: Implications for epigenetic activation of the Jak/STAT pathway
-
10.1182/blood-2003-06-2007 1:CAS:528:DC%2BD2cXlt1Krt7c%3D 14976049
-
C.S. Chim T.K. Fung W.C. Cheung R. Liang Y.L. Kwong 2004 SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway Blood 103 4630 4635 10.1182/blood-2003-06-2007 1:CAS:528:DC%2BD2cXlt1Krt7c%3D 14976049
-
(2004)
Blood
, vol.103
, pp. 4630-4635
-
-
Chim, C.S.1
Fung, T.K.2
Cheung, W.C.3
Liang, R.4
Kwong, Y.L.5
-
66
-
-
42649089780
-
The methylome: Approaches for global DNA methylation profiling
-
10.1016/j.tig.2008.01.006 1:CAS:528:DC%2BD1cXlslWisbs%3D 18325624
-
S. Beck V.K. Rakyan 2008 The methylome: approaches for global DNA methylation profiling Trends Genet 24 231 237 10.1016/j.tig.2008.01.006 1:CAS:528:DC%2BD1cXlslWisbs%3D 18325624
-
(2008)
Trends Genet
, vol.24
, pp. 231-237
-
-
Beck, S.1
Rakyan, V.K.2
|